Cargando…

Effect of loading dose of atorvastatin therapy prior to percutaneous coronary intervention in patients with acute coronary syndrome: a meta-analysis of six randomized controlled trials

PURPOSE: The study sought to summarize the evidence of pre-procedural atorvastatin therapy to improve the prognosis of acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI). PATIENTS AND METHODS: We searched PubMed and Embase from inception to July 2018 for rando...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Mingfeng, Bu, Lixia, Shi, Li, Guo, Renwei, Yang, Bin, Cao, Huili, Luo, Liangping, Lu, Ligong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585398/ https://www.ncbi.nlm.nih.gov/pubmed/31354240 http://dx.doi.org/10.2147/DDDT.S196588

Ejemplares similares

Comparison of the Treatment Efficacy of Rosuvastatin versus Atorvastatin Loading Prior to Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction
por: Adel, Esraa M., et al.
Publicado: (2022)

High-dose atorvastatin reduces the risk of cardiovascular events in patients with percutaneous coronary intervention
por: Lu, Changqing, et al.
Publicado: (2017)

Cardioprotective Effects of Atorvastatin plus Trimetazidine in Percutaneous Coronary Intervention
por: Lin, Xuefeng, et al.
Publicado: (2013)

Effects of atorvastatin loading prior to primary percutaneous coronary intervention on endothelial function and inflammatory factors in patients with ST-segment elevation myocardial infarction
por: YONG, HUIJUAN, et al.
Publicado: (2014)

Does Pre-Treatment with High Dose Atorvastatin Prevent Microvascular Dysfunction after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome?
por: Lee, Bong-Ki, et al.
Publicado: (2016)

Immediate Results and Six-Month Clinical Outcome after Percutaneous Coronary Intervention in Patients with Prior Coronary Artery Bypass Surgery
por: Behboudi, Fatemeh, et al.
Publicado: (2011)

High-dose atorvastatin pretreatment could diminishes microvascular impairment in patients undergoing elective percutaneous coronary intervention
por: He, Gui-Xin, et al.
Publicado: (2013)

Simultaneous administration of high-dose atorvastatin and clopidogrel does not interfere with platelet inhibition during percutaneous coronary intervention
por: Kreutz, Rolf P, et al.
Publicado: (2016)

Percutaneous Coronary Intervention versus Coronary Artery Bypass Graft in Acute Coronary Syndrome patients with Renal Dysfunction
por: Zhang, Xiaojia, et al.
Publicado: (2018)

The renoprotective effects of simvastatin and atorvastatin in patients with acute coronary syndrome undergoing percutaneous coronary intervention: An observational study
por: Ma, Huan, et al.
Publicado: (2017)

Coronary Artery Bypass Grafting Among Patients With Prior Percutaneous Coronary Interventions
por: Kahlon, Ravi S., et al.
Publicado: (2018)

Comparison of percutaneous coronary intervention of native coronary artery versus bypass graft in patients with prior coronary artery bypass grafting
por: Yang, Zhiqiang, et al.
Publicado: (2023)

Does Prior Percutaneous Coronary Intervention Influence the Outcomes of Coronary Artery Bypass Surgery?
por: Miguel, Gade S. V., et al.
Publicado: (2020)

Comparison of Six Different Percutaneous Coronary Intervention Guidance Modalities
por: Hu, Mengjin, et al.
Publicado: (2022)

Prior Coronary Artery Bypass Graft Surgery and Outcome After Percutaneous Coronary Intervention: An Observational Study From the Pan‐London Percutaneous Coronary Intervention Registry
por: Rathod, Krishnaraj S., et al.
Publicado: (2020)

Comparison of lower loading dose of prasugrel with conventional loading dose of prasugrel in Indian patients undergoing percutaneous coronary interventions
por: Kumari, Priti, et al.
Publicado: (2018)

Effects of Statins on the Epicardial Fat Thickness in Patients with Coronary Artery Stenosis Underwent Percutaneous Coronary Intervention: Comparison of Atorvastatin with Simvastatin/Ezetimibe
por: Park, Jae-Hyeong, et al.
Publicado: (2010)

Prognostic Impact of Multiple Prior Percutaneous Coronary Interventions in Patients Undergoing Coronary Artery Bypass Grafting
por: Biancari, Fausto, et al.
Publicado: (2018)

Effect of High Dose Rosuvastatin Loading before Percutaneous Coronary Intervention on Contrast-Induced Nephropathy
por: Yun, Kyeong Ho, et al.
Publicado: (2014)

Comparing effectiveness of high-dose Atorvastatin and Rosuvastatin among patients undergone Percutaneous Coronary Interventions: A non-concurrent cohort study in India
por: Roy, Debabrata, et al.
Publicado: (2020)

Long-term benefits of high-intensity atorvastatin therapy in Chinese acute coronary syndrome patients undergoing percutaneous coronary intervention: A retrospective study
por: Liu, Hui, et al.
Publicado: (2018)

Therapeutic effects of atorvastatin and ezetimibe compared with double-dose atorvastatin in very elderly patients with acute coronary syndrome
por: Liu, Zhi, et al.
Publicado: (2017)

Effects of High-dose Atorvastatin Pretreatment in Patients with ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Cardiac Magnetic Resonance Study
por: Kim, Eun Kyoung, et al.
Publicado: (2015)

Comparison between rosuvastatin and atorvastatin for the prevention of contrast-induced nephropathy in patients with STEMI undergoing primary percutaneous coronary intervention
por: Firouzi, Ata, et al.
Publicado: (2018)

Eptifibatide Bolus Dose During Elective Percutaneous Coronary Intervention
por: Doustkami, Hossein, et al.
Publicado: (2018)

Percutaneous Coronary Intervention in Pregnancy: Modeling of the Fetal Absorbed Dose
por: Kuba, Kfier, et al.
Publicado: (2019)

Late Myocardial Infarction and Repeat Revascularization after Coronary Artery Bypass Grafting in Patients with Prior Percutaneous Coronary Intervention †
por: Biancari, Fausto, et al.
Publicado: (2022)

Sex-Specific Influence of the SCARB1 Rs5888 SNP on the Serum Lipid Response to Atorvastatin in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Wu, Dong-Feng, et al.
Publicado: (2020)

Treatment effect of metformin combined with atorvastatin in reducing in-stent restenosis after percutaneous coronary intervention in coronary artery disease patients with type 2 diabetic patients
por: Chen, Mingli, et al.
Publicado: (2022)

Impact of prior cerebrovascular events on patients with unprotected left main coronary artery disease treated with coronary artery bypass grafting or percutaneous coronary intervention
por: Pan, Yu, et al.
Publicado: (2021)

Triglyceride-glucose index is associated with poor prognosis in acute coronary syndrome patients with prior coronary artery bypass grafting undergoing percutaneous coronary intervention
por: Dong, Shutong, et al.
Publicado: (2023)

Chronic Total Occlusion Percutaneous Coronary Intervention in Patients With Prior Coronary Artery Bypass Graft: Current Evidence and Future Perspectives
por: Guo, Lei, et al.
Publicado: (2022)

Bivalirudin in percutaneous coronary intervention
por: Lehman, Sam J, et al.
Publicado: (2006)

Percutaneous Coronary Intervention in the Elderly
por: Walsh, Simon J, et al.
Publicado: (2007)

Percutaneous Coronary Interventions in Women
por: Joodi, Golsa, et al.
Publicado: (2023)

Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in Chinese patients with acute coronary syndrome: A systematic review and meta-analysis
por: Ye, Ziliang, et al.
Publicado: (2017)

The Role of Coronary Physiology in Contemporary Percutaneous Coronary Interventions
por: Marin, Federico, et al.
Publicado: (2022)

Left Main Coronary Artery Percutaneous Coronary Intervention
por: Ferrante, Arnaud, et al.
Publicado: (2022)

Effects of high dose atorvastatin before elective percutaneous coronary intervention on highly sensitive troponin T and one year major cardiovascular events; a randomized clinical trial()
por: Pourhosseini, HamidReza, et al.
Publicado: (2019)

Ischemic and Bleeding Risk After Percutaneous Coronary Intervention in Patients With Prior Ischemic and Hemorrhagic Stroke
por: Natsuaki, Masahiro, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fhd6acmq3nenvs1ef0tre23fc8